Bridgehead International

US Expansion continues

May 2008

Susan Garfield joins Bridgehead International Boston office

Susan Garfield has joined Bridgehead International as VP, Bridgehead USA Inc. and will head up the company's Boston office. Susan is a market access, reimbursement and economics strategist, with an expertise in demand creation and advocacy. For over 12 years, Susan's professional career has focused on innovations in healthcare, the economics of practice change, and the role of reimbursement and policy to the adoption of new technologies. Her work has included economic modelling, coding analyses and applications, payer coverage campaigns, market strategies for innovative technologies, health policy development, government relations, and creating partnerships between industry and advocacy groups.

Prior to joining Bridgehead, Susan was Director, Global Reimbursement, Policy and Economic Strategy at QIAGEN Corporation (formally Digene Corporation). Before QIAGEN, Susan was a Director at Boston Healthcare Consulting. During her tenure there, she worked with biotechnology, medical device, pharmaceutical, and diagnostic firms on market access strategy and execution. In this role Susan translated primary research with over 2,000 clinicians, payers, government decision-makers and patients into actionable programs for clients.

Susan received her BA in English and Women's Studies from the University of Pennsylvania, a Master's of Science in Population and Development from the London School of Economics, and a Master's of Science in Health Policy and Management from Harvard University, School of Public Health. She is currently completing the Doctorate of Public Health program at Boston University.

Bridgehead International CEO, Timothy Fitzgerald commented: "We are delighted at Susan's decision to join the team, at a time when we are pushing ahead with a major expansion of our activities in North America. Her expertise and experience, particularly in market access and reimbursement, will be of real value to Bridgehead and our clients."

Over the past four years Bridgehead's Market Access business has grown to be the single largest practice area in the company.

Whilst much of Bridgehead's work on pricing, reimbursement and market access is global in nature (US, top five Europe and Japan), the company is being increasingly asked to use its knowledge and experience to address US-specific issues, through:

• Payer research
• Therapy area scanning
• Pricing strategy for commercialisation
• Reimbursement negotiation strategy
• Product life cycle pricing strategy
• Pharmacoeconomic assessments
• Health technology assessment support

Top

About Bridgehead International

Bridgehead International is a leading biopharmaceutical consultancy group, offering a range of services designed to assist clients in achieving extraordinary growth across the product and technology value chain, through three practice areas:

• Market Access Solutions, including market assessments and development of pricing and reimbursement strategies.
• Technical and Commercial Evaluation, covering due diligence, expert reports and decision support.
• Healthcare Education Services, focused on specialist medical education for those working in the pharmaceutical and biotechnology industry.

With over 50 consultants and associates in Europe, North America and Asia, Bridgehead Consulting provides a powerful combination of strategic, scientific, medical, technical, commercial, economic, decision support, modelling and intellectual property skills and experience.

Contact: +44 1664 503 700, info@bridgehead.com or visit us at www.bridgehead.com